Your browser doesn't support javascript.
loading
Effects of hyperoxemia in patients with sepsis - A post-hoc analysis of a multicentre randomized clinical trial.
Catalisano, G; Ippolito, M; Blanda, A; Meessen, J; Giarratano, A; Todesco, N; Bonato, V; Restuccia, F; Montomoli, J; Fiore, G; Grasselli, G; Caironi, P; Latini, R; Cortegiani, A.
Afiliação
  • Catalisano G; Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy.
  • Ippolito M; Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy; Department of Anaesthesia, Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Italy.
  • Blanda A; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri - IRCCS, Italy.
  • Meessen J; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri - IRCCS, Italy.
  • Giarratano A; Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy; Department of Anaesthesia, Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Italy.
  • Todesco N; Servizio di Anestesia, Rianimazione e Terapie Intensive, Azienda Sanitaria Friuli Occidentale, P.O. Santa Maria degli Angeli, Pordenone, Italy.
  • Bonato V; S.C. Anestesia e Rianimazione, Ospedale SS. Arrigo e Biagio, Alessandria, Italy.
  • Restuccia F; Department of Anesthesiology and Critical Care Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Montomoli J; Department of Anesthesia and Intensive Care, Infermi Hospital, AUSL Romagna, Rimini, Italy.
  • Fiore G; S.C. Anestesia e Rianimazione Moncalieri-Carmagnola (TO), Dipartimento Area Chirurgica, ASLTO5, Italy.
  • Grasselli G; Department of Anesthesia, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Italy.
  • Caironi P; Department of Anaesthesia and Critical Care, AOU S. Luigi Gonzaga, Department of Oncology, University of Turin, Italy.
  • Latini R; Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri - IRCCS, Italy.
  • Cortegiani A; Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy; Department of Anaesthesia, Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Italy. Electronic address: andrea.cortegiani@unipa.it.
Pulmonology ; 2023 Mar 10.
Article em En | MEDLINE | ID: mdl-36907813
BACKGROUND: Administration of supplemental oxygen is a life-saving treatment in critically ill patients. Still, optimal dosing remains unclear during sepsis. The aim of this post-hoc analysis was to assess the association between hyperoxemia and 90-day mortality in a large cohort of septic patients. METHODS: This is a post-hoc analysis of the Albumin Italian Outcome Sepsis (ALBIOS) randomized controlled trial (RCT). Patients with sepsis who survived the first 48 h since randomization were included and stratified into two groups according to their average PaO2 levels during the first 48 h (PaO2 0-48 h). The cut-off value was established at 100 mmHg (average PaO2 0-48 h >100 mmHg: hyperoxemia group; PaO2 0-48h≤100: normoxemia group). The primary outcome was 90-day mortality. RESULTS: 1632 patients were included in this analysis (661 patients in the hyperoxemia group, 971 patients in the normoxemia group). Concerning the primary outcome, 344 (35.4%) patients in the hyperoxemia group vs. 236 (35.7%) in the normoxemia group had died within 90 days from randomization (p = 0.909). No association was found after adjusting for confounders (HR 0.87; CI [95%] 0.736-1.028, p = 0.102) or after excluding patients with hypoxemia at enrollment, patients with lung infection or including post-surgical patients only. Conversely, we found an association between lower risk of 90-day mortality and hyperoxemia in the subgroup including patients who had the lung as primary site of infection (HR 0.72; CI [95%] 0.565-0.918). Mortality at 28 days, ICU mortality, incidence of acute kidney injury, use of renal replacement therapy, days to suspension of vasopressor or inotropic agents, and resolution of primary and secondary infections did not differ significantly. Duration of mechanical ventilation and length of stay in ICU were significantly longer in patients with hyperoxemia. CONCLUSIONS: In a post-hoc analysis of a RCT enrolling septic patients, hyperoxemia as average PaO2>100 mmHg during the first 48 h was not associated with patients' survival.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Pulmonology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Pulmonology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália